On First Day
The workshop is designed to provide “business case” exposure to participants on day-to-day topics, including:
- How to properly interact with healthcare professionals (doctors, nurses, pharmacists, etc) for promotional and medical information sharing
- How to set up and run a successful compliance program in your organization
- How to ethically interact with patient organizations
- How to create promotional material and write/approve copies and artwork
- How to determine promotional methods including professional representation, hospitality to Healthcare Professionals and the use of audio-visual related communication technologies in the organization of educational events
- How to ethically use frontier technologies in healthcare (AI, genome editing, etc)
- How to increase the level of ethical conduct of activities in your organization
Participants will receive an update on the IFPMA Code and the respective interpretation – trainers are keen to engage and exchange with the audience on local implementation.
Who should attend?
- Anybody within a biopharmaceutical company who is responsible for medical or commercial activities with HCPs and or HCOs, who supports the business with the interpretation of current local or global standards or who is part of the review or approval process for these activities
- Ethics & Compliance professionals
- Medical and scientific advisors and directors
- Personnel responsible for the development and certification of promotional materials
- Sales and marketing representatives
- General managers
- In-house counsels and other related staff
- Representatives from national/regional pharmaceutical trade associations
On Second Day
This half-day forum aims to engage stakeholders to join forces to move ahead. The focus is on how trust in health authorities and healthcare professionals is paramount in implementing a fully efficient healthcare system.
The forum is designed as a roundtable discussion between various invited stakeholders. Other participants are welcome as observers and can engage in the Q&A session.
Round table participants will address the progress that Kenya has made in raising its standards in the ethics and business integrity space, which is contributing to IFPMA’s goal to create a level playing field in the market.
Who should attend?
- Government officials
- Medical societies
- Patient organizations
- Representatives from biopharmaceutical companies and national/regional pharmaceutical trade associations (Compliance professionals, General Managers, in-house counsels, and other related staff)